BlackRock Inc. boosted its position in shares of Calyxt Inc (NASDAQ:CLXT) by 21.8% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 733,554 shares of the company’s stock after buying an additional 131,265 shares during the quarter. BlackRock Inc.’s holdings in Calyxt were worth $13,696,000 as of its most recent SEC filing.
Other large investors have also recently bought and sold shares of the company. Granite Investment Partners LLC bought a new stake in shares of Calyxt during the 2nd quarter valued at $216,000. Wells Fargo & Company MN raised its position in shares of Calyxt by 23.6% during the 1st quarter. Wells Fargo & Company MN now owns 38,048 shares of the company’s stock valued at $500,000 after acquiring an additional 7,260 shares during the last quarter. Finally, Perkins Capital Management Inc. bought a new stake in shares of Calyxt during the 2nd quarter valued at $833,000. 28.00% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Calyxt stock opened at $12.04 on Thursday. The firm has a market cap of $394.63 million, a price-to-earnings ratio of -10.75 and a beta of 3.61. Calyxt Inc has a 52 week low of $11.42 and a 52 week high of $27.23. The company has a debt-to-equity ratio of 0.16, a current ratio of 21.27 and a quick ratio of 21.27.
In other Calyxt news, insider Daniel F. Voytas sold 4,083 shares of the company’s stock in a transaction on Wednesday, August 8th. The shares were sold at an average price of $17.48, for a total transaction of $71,370.84. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Manoj Sahoo sold 2,521 shares of the company’s stock in a transaction on Monday, October 1st. The shares were sold at an average price of $14.84, for a total transaction of $37,411.64. The disclosure for this sale can be found here. Insiders have sold a total of 25,219 shares of company stock valued at $402,335 in the last quarter. Corporate insiders own 2.80% of the company’s stock.
Several analysts have commented on CLXT shares. Zacks Investment Research upgraded shares of Calyxt from a “hold” rating to a “buy” rating and set a $15.00 target price for the company in a research report on Thursday, October 11th. Goldman Sachs Group started coverage on shares of Calyxt in a research report on Friday, September 7th. They set a “neutral” rating and a $18.00 target price for the company. Finally, ValuEngine upgraded shares of Calyxt from a “hold” rating to a “buy” rating in a research report on Friday, July 20th. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $23.25.
Calyxt Company Profile
Calyxt, Inc, a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for plants in the United States. It engages in the development of high oleic soybeans, high fiber wheat, herbicide tolerant wheat, powdery mildew resistant wheat, improved oil composition canola, herbicide tolerant canola, improved quality alfalfa and herbicide tolerant alfalfa, late blight resistant potatoes, cold storable/reduced browning potatoes, improved protein composition soybeans, drought tolerant soybeans, herbicide tolerant soybeans, and improved yield soybeans.
Featured Article: What impact do institutional investors have on markets?
Want to see what other hedge funds are holding CLXT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Calyxt Inc (NASDAQ:CLXT).
Receive News & Ratings for Calyxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt and related companies with MarketBeat.com's FREE daily email newsletter.